Fig. 4From: Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort studyHazard ratios and 95% CI for effectiveness outcomes in geriatric subgroupsBack to article page